Michael Markey
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 4
- DNA Repair Mechanisms 4
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
- TGF-β signaling in diseases 2
- Melanoma and MAPK Pathways 2
- RNA Research and Splicing 2
- Oncology 13
- Cancer-related Molecular Pathways 11
- Co-authors
- Erik S. Knudsen (6 shared papers)Steven P. Angus (4 shared papers)Steven J. Berberich (3 shared papers)Bruce J. Aronow (2 shared papers)Sarah Williams (2 shared papers)Larry G. Arlian (1 shared paper)Marjorie S. Morgan (1 shared paper)Ranjaka W. Gunawardena (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Oncogene (2 papers)PLoS ONE (2 papers)Clinical Cancer Research (1 paper)Frontiers in bioscience (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Michael Markey
24 papers receiving 678 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 152
- Oncology 275
- Molecular Biology 480
- Ophthalmology 52
- Cell Biology 64
Countries citing papers authored by Michael Markey
This map shows the geographic impact of Michael Markey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Markey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Markey more than expected).
Fields of papers citing papers by Michael Markey
This network shows the impact of papers produced by Michael Markey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Markey. The network helps show where Michael Markey may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Markey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. | 2002 | 99 |
| 2 | 2012 | 76 | |
| 3 | 2002 | 75 | |
| 4 | 2007 | 66 | |
| 5 | 2013 | 44 | |
| 6 | 2006 | 38 | |
| 7 | 2004 | 36 | |
| 8 | 2011 | 36 | |
| 9 | 2002 | 31 | |
| 10 | 2008 | 29 | |
| 11 | 2010 | 21 | |
| 12 | 2004 | 21 | |
| 13 | Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration. | 2017 | 19 |
| 14 | 2015 | 17 | |
| 15 | 2009 | 17 | |
| 16 | 2016 | 13 | |
| 17 | 2018 | 12 | |
| 18 | 2017 | 12 | |
| 19 | 2023 | 9 | |
| 20 | 2017 | 5 |
About Michael Markey
Michael Markey is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Ophthalmology, having authored 24 papers that have together received 686 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Epigenetics and DNA Methylation (4 papers), DNA Repair Mechanisms (4 papers), RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers), TGF-β signaling in diseases (2 papers), Melanoma and MAPK Pathways (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (152 citations), Oncology (275 citations), Molecular Biology (480 citations), Ophthalmology (52 citations) and Cell Biology (64 citations). Michael Markey has collaborated with scholars based in United States and Germany. Frequent co-authors include Erik S. Knudsen, Steven P. Angus, Steven J. Berberich, Bruce J. Aronow, Sarah Williams, Larry G. Arlian, Marjorie S. Morgan, Ranjaka W. Gunawardena, Matthew W. Strobeck and Benjamin R. Bates. Their work appears in journals such as Journal of Biological Chemistry, Oncogene, PLoS ONE, Clinical Cancer Research and Frontiers in bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.